Sfoglia per Rivista VIRUSES
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines
2012-01-01 Clementi, Nicola; Criscuolo, Elena; Castelli, Matteo; Mancini, Nicasio; Clementi, Massimo; Burioni, Roberto
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)
2012-01-01 Sautto, G; Mancini, Nicasio; Clementi, Massimo; Burioni, Roberto
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
2022-01-01 Focosi, D.; Maggi, F.; Casadevall, A.
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?
2012-01-01 Mancini, Nicasio; Sautto, G; Clementi, Nicola; Diotti, Ra; Castelli, M; Criscuolo, E; Solforosi, L; Clementi, Massimo; Burioni, Roberto; Castelli, Matteo; Criscuolo, Elena
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2
2022-01-01 Criscuolo, Elena; Giuliani, Benedetta; Ferrari, Davide; Ferrarese, Roberto; Diotti, Roberta A; Clementi, Massimo; Mancini, Nicasio; Clementi, Nicola
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
2021-01-01 Focosi, Daniele; Tuccori, Marco; Baj, Andreina; Maggi, Fabrizio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines | 1-gen-2012 | Clementi, Nicola; Criscuolo, Elena; Castelli, Matteo; Mancini, Nicasio; Clementi, Massimo; Burioni, Roberto | |
| Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII) | 1-gen-2012 | Sautto, G; Mancini, Nicasio; Clementi, Massimo; Burioni, Roberto | |
| Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence | 1-gen-2022 | Focosi, D.; Maggi, F.; Casadevall, A. | |
| Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? | 1-gen-2012 | Mancini, Nicasio; Sautto, G; Clementi, Nicola; Diotti, Ra; Castelli, M; Criscuolo, E; Solforosi, L; Clementi, Massimo; Burioni, Roberto; Castelli, Matteo; Criscuolo, Elena | |
| Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 | 1-gen-2022 | Criscuolo, Elena; Giuliani, Benedetta; Ferrari, Davide; Ferrarese, Roberto; Diotti, Roberta A; Clementi, Massimo; Mancini, Nicasio; Clementi, Nicola | |
| SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies | 1-gen-2021 | Focosi, Daniele; Tuccori, Marco; Baj, Andreina; Maggi, Fabrizio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile